Clinical Trials
All Clinical Trials - Page 19 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06109649Phase 3Active Not Recruiting
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Afamelanotide
- NCT05971849Phase 1Completed
Dampening the Reproductive Axis With Continuous Kisspeptin
Kisspeptin
- NCT05478707Phase 2Recruiting
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Dulaglutide
- NCT06059118Phase 2Recruiting
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Gonadorelin
- NCT05751720Phase 1/Phase 2Unknown
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
Tirzepatide
- NCT06298799N/AUnknown
GENETIC VARIABILITY TO GLP1 TREATMENT
Semaglutide
- NCT06097390Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
Semaglutide
- NCT06010004Phase 3Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Orforglipron
- NCT06065540Phase 3Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Semaglutide
- NCT05371028N/ACompleted
A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Teduglutide
- NCT05813912Phase 3Completed
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Semaglutide
- NCT06045221Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Semaglutide
- NCT06037252Phase 2Active Not Recruiting
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Tirzepatide
- NCT06023095Phase 1Completed
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
Orforglipron
- NCT06047548Phase 3Completed
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT06739044Phase 3Completed
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Semaglutide
- NCT06024356N/ACompleted
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT07309094N/ARecruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Tirzepatide
- NCT06041217Phase 3Completed
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
Semaglutide
- NCT06064006Phase 2Completed
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
Amycretin
- NCT06049329Phase 1Completed
A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
Amycretin
- NCT06009653Phase 4Withdrawn
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Tirzepatide
- NCT06045260Phase 2Recruiting
"Receptor Radionuclide Therapy With 177Lu-DOTATOC
Octreotide
- NCT06039826Phase 1Completed
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Retatrutide
- NCT06145438Phase 3Completed
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Gonadorelin
- NCT04972721N/ACompleted
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Semaglutide
- NCT06178146Phase 4Unknown
Thymosin Alpha-1 for irAE Secondary to ICIs
Thymosin-Alpha-1
- NCT07374445Phase 4Completed
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Liraglutide
- NCT06331286N/AUnknown
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
Dulaglutide
- NCT06003465Phase 1Completed
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Retatrutide
- NCT05724134Phase 1Completed
Pancreatic Clamp in NAFLD
Octreotide
- NCT06061354Phase 4Unknown
Teriparatide on Maxillary Sinus Floor Osseointegration
Teriparatide
- NCT06062719Phase 2/Phase 3Unknown
Role of Octreotide in Non Variceal Bleeding
Octreotide
- NCT05963022Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Tirzepatide
- NCT06143033N/ACompleted
A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area
Argireline
- NCT05996848Phase 3Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Semaglutide
- NCT06145308Phase 2Recruiting
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Gonadorelin
- NCT06085976Phase 2Unknown
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Octreotide
- NCT05617885Phase 1Completed
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
Gonadorelin
- NCT05971940Phase 3Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Orforglipron
- NCT05984238N/ACompleted
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
Semaglutide
- NCT05931367Phase 3Completed
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Retatrutide
- NCT05990374N/AUnknown
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Tirzepatide
- NCT05920889Phase 2Completed
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Semaglutide
- NCT05897372Phase 2Terminated
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Semaglutide
- NCT06091735N/ACompleted
Clinical Study of Bowel Preparation Before Colonoscopy
Linaclotide
- NCT05978713Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Tirzepatide
- NCT05931380Phase 3Completed
A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
Orforglipron
- NCT05568550Phase 2Recruiting
Pembro With Radiation With or Without Olaparib
Gonadorelin
- NCT06005012Phase 2Active Not Recruiting
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Semaglutide